Switch Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
March 14, 2023
Vertical
Biotechnology
Funding Amount
$52,000,000
Company Info
Founders
Dee Datta, Ph.D.
Market
Healthcare
Location
San Francisco, CA, USA
Coinvestors
BOLD Capital Partners, Digitalis Ventures, Eli Lilly and Company, Insight Partners, Ono Venture Investment, UCB Ventures, Upfront Ventures
Company Description

Switch Therapeutics is a biotech company that develops RNAi therapies.